Bicycle Therapeutics plc (NASDAQ: BCYC) is a clinical-stage pharmaceutical company focusing on developing novel medicines known as Bicycle® molecules for diseases that lack effective treatments.
Recent Developments:
Announced a workforce reduction aimed at reducing operating costs by approximate...